MORN trades 15.7% below Wall Street's consensus target of $227.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes MORN achieves its forward estimates and maintains a stable P/E multiple of 15.9x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 25, 2026, Morningstar, Inc. (MORN) has a Wall Street consensus price target of $227.33, based on estimates from 6 covering analysts. With the stock currently trading at $196.41, this represents a potential upside of +15.7%. The company has a market capitalization of $7.37B.
Analyst price targets range from a low of $210.00 to a high of $260.00, representing a 22% spread in expectations. The median target of $212.00 differs from the mean, suggesting potential outlier estimates. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, MORN trades at a trailing P/E of 22.1x and forward P/E of 15.9x. The forward PEG ratio of 1.40 indicates reasonable valuation for growth. Analysts expect EPS to grow +11.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $254.07, with bear and bull scenarios of $160.06 and $334.76 respectively. Model confidence stands at 53/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MSCIMSCI Inc. | $40.4B | $556.08 | $701.71 | +26.2% | Buy | 28.2x | 27 |
 SPGIS&P Global Inc. | $118.9B | $403.25 | $512.25 | +27.0% | Buy | 22.6x | 28 |
 MCOMoody's Corporation | $81.0B | $467.59 | $540.60 | +15.6% | Buy | 27.6x | 32 |
 FDSFactSet Research Systems Inc. | $9.6B | $271.25 | $256.75 | -5.3% | Hold | 15.2x | 30 |
 ICEIntercontinental Exchange, Inc. | $88.5B | $156.93 | $184.50 | +17.6% | Buy | 19.4x | 36 |
 LSELeishen Energy Holding Co., Ltd. | $90M | $5.29 | — | — | — | — | — |
 VRSKVerisk Analytics, Inc. | $22.0B | $168.65 | $225.43 | +33.7% | Hold | 21.9x | 25 |
 TRIThomson Reuters Corporation | $43.8B | $100.32 | $133.25 | +32.8% | Buy | 22.5x | 27 |
 BLKBlackRock, Inc. | $166.4B | $1073.45 | $1337.86 | +24.6% | Buy | 19.1x | 33 |
 TROWT. Rowe Price Group, Inc. | $22.3B | $104.27 | $113.50 | +8.9% | Hold | 10.2x | 38 |
Quick answers to the most common questions about buying MORN stock.
Morningstar, Inc. (MORN) has a consensus 12-month price target of $227.33, implying 15.7% upside from $196.41. The 6 analysts covering MORN see moderate appreciation potential.
MORN has a consensus rating of "Hold" based on 6 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $227.33 implies 15.7% upside from current levels.
With a forward P/E of 15.9478x, MORN trades at a relatively low valuation. The consensus target of $227.33 implies 15.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $260 for MORN, while the most conservative target is $210. The consensus of $227.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $335 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
MORN is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MORN stock forecast based on 6 Wall Street analysts shows a consensus price target of $227.33, with estimates ranging from $210 (bear case) to $260 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $254, with bear/bull scenarios of $160/$335.
Our quantitative valuation model calculates MORN's fair value at $254 (base case), with a bear case of $160 and bull case of $335. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.
MORN trades at a forward P/E ratio of 15.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on MORN, with a "Hold" consensus rating and $227.33 price target (15.7% upside). 2 of 6 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MORN analyst price targets range from $210 to $260, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $227.33 consensus represents the middle ground. Our model's $160-$335 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.